EVENTS|NEWS|CONTACT|DONATE

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Read Our Newsletter

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Day

March 24, 2026

H. Pylori and Gastric Cancer: What to Know About this Common Gut Infection

The bacterium Helicobacter pylori (H. pylori) commonly infects the stomach lining and is known to be a major risk factor for gastric...

Social Media

Newsroom

For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org

Categories

Foundation News
Press Releases
Research News
Your New Normal

Tags

adenocarcenoma advanced stage alcohol antibody biomarker blood chemoradiotherapy chemotherapy clinical trial clinical trials detection drugs endoscopy Epstein-Barr esophagogastric FDA gastrectomy gastric cancer registry gastroesophageal genes heartburn helicobacter pylori HER2 immunotherapy keytruda lonsurf metastatic nutrition peritoneal postoperative prevention proton pump inhibitor recovery recurrence research risk screening side-effects studies surgery survival treatment tumor virus women

Gastric Cancer Foundation

Tax ID 27-2978173

info@gastriccancer.org

PO Box 6279
Albany, CA 94706

Site Map

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Social Feed

Gastric Cancer Foundation

1 week ago

What is the role of biomarker testing in gastric cancer and how can the results shape individualized treatment plans? Oncologists from Memorial Sloan Kettering Cancer Center and Seton Hall University discuss those topics and more in this video series from OncLive. ... See MoreSee Less

Updates on the Evolving Landscape of FGFR2b Targeted Treatments in Gastric Cancer | OncLive Insights | OncLive

www.onclive.com

Updates on the Evolving Landscape of FGFR2b Targeted Treatments in Gastric Cancer | OncLive Insights | OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews...

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

Erena Shimoda, photographer and creator of the Underwater Transformation Project, captures the beauty of patients' bodies - helping survivors find the positivity in their scars, weight loss, and other transformations. Episode 2 of Your New Normal: "Your Body and Identity" is now on gastriccancer.org. ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

Join Hans Rueffert and special guests for this exploration of how to cope with body changes after cancer. “Cancer changes not just how you live but how you feel in your own skin. Your body may not look the way it used or even move the way it once did and that can leave you feeling uncertain, frustrated or even invisible." In this episode we’ll talk about “what it means to feel strong in a body that’s been through so much,” says Rueffert. ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

The FDA granted orphan drug designation to Dewpoint Therapeutics’ first-in-class condensate modulator for gastric cancer, which will begin clinical testing soon. ... See MoreSee Less

FDA Grants Orphan Drug Designation to DPTX3186 in Gastric Cancer | OncLive

www.onclive.com

The FDA granted orphan drug designation to DPTX3186 in gastric cancer.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

2 weeks ago

A study led by Yale researchers found that among gastric cancer patients in seven high-risk US states, there are significant racial and geographic differences in five-year survival rates. “The findings highlight persistent disparities in stage distribution and survival, underscoring the urgent need for tailored, community-centered prevention strategies to reduce these gaps,” says first author Chul S. Hyun. Via Yale Medicine School ... See MoreSee Less

New Study Highlights Need for Coordinated Approach to Stomach Cancer Screening and Prevention

medicine.yale.edu

A new study led by researchers at Yale School of Medicine sheds new light on the incidence rates, stage of diagnosis, and racial and geographic differences in

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Subscribe to Our Newsletter

We’ll deliver our monthly newsletter to your Inbox with Foundation updates, news about cutting edge research and trends in the field, and how to make a difference.

© 2024 Gastric Cancer Foundation. All Rights Reserved.

EVENTS | NEWS | CONTACT | DONATE

X